Clinical trial
ABRIDGE: Low Molecular Weight Heparin in Bridging Patients After Mechanical…
NCT00298285 · The Cleveland Clinic, Other · Completed
Key facts
| NCT number | NCT00298285 |
|---|---|
| Title | ABRIDGE: Low Molecular Weight Heparin in Bridging Patients After Mechanical Valve Replacement |
| Official title | ABRIDGE: Low Molecular Weight Heparin in Bridging Patients After Mechanical Valve Replacement. A Pilot Study |
| Lead sponsor | The Cleveland Clinic, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Mechanical Valve Replacement, Warfarin Therapy |
| Intervention type | Drug |
| Interventions | enoxaparin |
| Enrollment | 100 |
| Completion | Oct 1, 2006 |
| First posted | Mar 2, 2006 |
| Last update posted | Nov 9, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: